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Abstract
Introduction Adult mesenchymal stem cell therapy has a
potential application in the biological treatment of disc
degeneration. Our objectives were: to direct adipose-derived
mesenchymal stem cells (AD-MSC) from the sand rat to
produce a proteoglycan and collagen type I extracellular matrix
(ECM) rich in known ECM components of the annulus fibrosis
of disc; and to stimulate proteoglycan production by co-culture
of human annulus cells with AD-MSC.
Methods AD-MSC were isolated and characterised by
adherence to plastic, appropriate expression of cluster of
differentiation (CD) markers, and differentiation to osteoblasts
and chondrocytes in vitro. AD-MSC were grown in three-
dimensional (3D) culture and treated with or without
transforming growth factor beta (TGFβ) to direct them to
produce annulus-like ECM as determined by proteoglycan
content and collagen expression. AD-MSC were co-cultured
with human annulus cells and grown in 3D culture.
Results AD-MSC produced a proteoglycan and collagen type I
rich ECM after treatment with TGFβ in 3D culture as confirmed
by a 48% increase in proteoglycan content assayed by 1,9-
dimethylmethylene blue (DMB), and by immunohistochemical
identification of ECM components. Co-culture of human annulus
and sand rat AD-MSC in 3D culture resulted in a 20% increase
in proteoglycan production compared with the predicted value
of the sum of the individual cultures.
Conclusion Results support the hypothesis that AD-MSC have
potential in cell-based therapy for disc degeneration.
Introduction
Previous research has shown that adult mesenchymal stem
cells have the potential for biological cell-based treatment of
disc degeneration [1,2]. Degenerated discs have a decreased
proteoglycan content associated with a loss of load-bearing
function. Harvesting disc cells from the acellular disc tissue is
difficult because of the low numbers of disc cells and many of
the cells show senescence [3], programmed cell death [4], or
decreased or altered extracellular matrix (ECM) expression [5].
Stem cells are characterised by their ability to differentiate into
lineage-specific cell types [6-8]. Bone-marrow derived mesen-
chymal stem cells (BM-MSC) transplanted to degenerative
discs in rabbits were found to proliferate and differentiate into
cells expressing some of the major extracellular components
of discs [9]. BM-MSC injected into canine discs was partially
effective in inhibiting disc degeneration and may be responsi-
ble for maintaining disc immune privilege [10].
3D = three dimensional; AD-MSC = adipose-derived mesenchymal stem cells; BM-MSC = bone-marrow derived mesenchymal stem cells; BMP = 
bone morphogenic protein; CD = cluster of differentiation; CFSE = carboxyfluorescein diacetate succinimidyl ester; CM = conditioned media; DMB 
= 1,9-dimethylmethylene blue; ECM = extracellular matrix; HBSS = Hank's Buffered Salt Solution; IGF-1 = insulin-like growth factor 1; MSCBM = Page 1 of 10
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mesenchymal stem cell basal media; SMAD = small mothers against decapentaplegic homolog; TGFβ = transforming growth factor beta.
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some advantages as an attractive, readily available adult stem
cell because of the ease of harvest and their abundance
[11,12]. AD-MSC are capable of differentiating into adi-
pocytes, chondrocytes and osteoblasts, and, more recently,
have been shown to differentiate into insulin-, somatostatin-
and glucagon-expressing cells [13]. AD-MSC have great
potential as a carrier for therapeutic growth factors. For exam-
ple, AD-MSC genetically modified by bone morphogenic pro-
tein 2 (BMP-2) produced a significant increase of newly
formed bone in a canine bone defect study [14]. Some of the
most potent inducers of chondrogenic differentiation are mem-
bers of the transforming growth factor-beta (TGFβ) super fam-
ily such as the TGFβ isoforms and the BMPs [15]. Also
important are the fibroblast growth factor isoforms and insulin-
like growth factor (IGF-1).
TGFβ super family cytokines act through binding to cell-sur-
face receptors. Differentiation occurs through two major intra-
cellular pathways: through the small mothers against
decapentaplegic homolog (SMAD) signalling transcription
factors; and through mitogen activated protein kinase. Syner-
gistic interactions between TGFβ and other cytokines, such as
IGF1, has been reported [16]. The IGF-1-activated signalling
cascade is hypothesised to interact with the TGFβ pathway.
Although the precise mechanism of action of TGFβ has not
been elucidated, the key events responsible for the differenti-
ation of mesenchymal cells to the chondrogenic lineage are
known to take place during the first days of growth factor
exposure [17]. TGFβ1 is a standard media additive used in
culture to induce chondrogenesis. TGFβ3 has been shown to
induce a more rapid and representative expression of chon-
drogenic markers [18].
Little is known about the effect of stem cells, or stem cell-con-
ditioned media (CM), on disc cells. Previous experiments with
disc cells have shown that co-culture of nucleus pulposus with
annulus fibrosis cells stimulated proliferation. Reinsertion into
the discs of rabbits retarded disc degeneration [19]. Other
work has demonstrated an increased synthesis of proteogly-
cans after pellet co-culture of disc cells with BM-MSC [20].
Stimulation of disc cells with stem cells or CM could enhance
the success of autologous implantation of disc cells.
In the present study we use two approaches to investigate
disc remediation via disc or stem cell stimulation. First, we
extract, characterize and stimulate AD-MSC obtained from the
sand rat with TGFβ treatment in 3D collagen sponges to pro-
duce a proteoglycan and collagen type I ECM, rich in known
disc ECM components. Second, we investigate the matrix
stimulatory effect of AD-MSC co-cultured in 3D culture with
human annulus fibrosis cells.
Materials and methods
Source of fat tissue
Animal studies were performed following approval by the
Carolinas Medical Center Institutional Animal Care and Use
Committee. Psammomys obesus, the sand rat, is used in our
laboratory in studies of disc degeneration. Colony housing and
animal diet descriptions have been published previously
[21,22]. Immediately after euthanasia, adipose tissue from the
back and inguinal areas was surgically obtained using sterile
techniques, placed in a petri dish containing Hank's Buffered
Salt Solution ([HBSS] Gibco, Carlsbad, CA) and rapidly trans-
ported to the laboratory. Approximately 2 g of fat tissue was
obtained per harvest and processed as described below.
AD-MSC isolation and plating
Cell culture methods were adapted from the method
described by Cowan et al. [2]. Fat was placed in a sterile petri
dish, minced well in HBSS, and digested with 1 mg/ml colla-
genase type II (Sigma, St. Louis, MO) at 37°C in a water-bath
shaker for 30 to 40 minutes at 180 to 200 rpm with a brief vor-
tex every 10 minutes. Undigested tissue was removed by filter-
ing through 100 μm nylon cell strainers (Falcon, Franklin
Lakes, NJ). Multipotent AD-MSC were harvested by centrifu-
gation at 42 g for five minutes at room temperature. The pellet
was then resuspended in 2 ml HBSS, filtered through a 40 μm
cell strainer, counted and plated as the primary culture (P0) on
100 × 20 mm round plastic tissue culture dishes (Primera, Fal-
con, BD Biosciences, San Jose, CA) at a density of 1000
cells/mm2. A density of 1000 cells/mm2 was chosen as a high
enough density for cell to cell contact but low enough to allow
space for several days of proliferation without the cells becom-
ing confluent. Cells were fed every 48 to 72 hours with 10 ml
media (Mesemchymal Stem Cell Basal Media [MSCBM],
Cambrex Bio Science, Walkersville, Baltimore, MD). When
confluent, cells were trypsinised, centrifuged at 42 g for five
minutes and re-plated at a density of 1000 cells/mm2.
Verifying stem cell isolation
CD marker analysis of AD-MSC
AD-MSC were characterised by localisation of the multipotent
mesenchymal stem cell markers CD105 and CD29 and nega-
tive localisation of CD45 and CD34 [23]. For cluster of differ-
entiation (CD) immunohistochemical assessment of stem cell
markers, AD-MSC were grown on two- and four-well Nunc
slides (Nalge Nunc international, Rochester, NY) (Table 1).
AD-MSC were harvested for CD analysis by scraping them off
the surface with plastic pipette tips. They then underwent cen-
trifugation at 42 g for five minutes, resuspension in 1% agar-
ose (Sigma, St. Louis, MO), fixation with 10% neutral buffered
saline (Allegiance, McGaw Park, IL) for 20 minutes, followed
by storage in 70% ethanol (AAPER, Shelbyville, KY) until proc-
essed for paraffin embedding.
The CD antibodies work to identify cells by immunohistochem-
ical visualisation. CD surface marker identification, along withPage 2 of 10
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the standard criteria suggested for defining mesenchymal
stem cells. Mesenchymal stem cells should characteristically
show positive localisation of CD44, CD29, CD105 and
CD90, but no localisation of haematopoietic markers CD45,
CD34 [23]. These sand rat-derived AD-MSC are positive for
the markers CD29 and CD105 and negative for the haemat-
opoietic markers CD45 and CD34. The readily available anti-
human markers CD90 and CD44 did not cross-react with
sand rat tissue; thus they were not tested in the present study.
Since anti-sand rat antibodies for CD markers are not commer-
cially available, the CD markers listed in Table 1 were first
tested for use by appropriate reactivity against sand rat lymph
nodes.
In order to further verify the lineage plasticity of AD-MSC, oste-
ogenic and chondrogenic differentiation was confirmed using
standard methods described below.
Osteogenic differentiation
Osteogenic differentiation of stem cells using an osteogenesis
kit (Chemicon International, Temecula, CA) [24] was con-
firmed by positive alizarin red staining of mineralised matrix
after 21 days of culture. Control cultures were only fed
MSCBM media.
Chondrogenic differentiation using micromass culture
Cells were grown for seven to 10 days in chondrogenic induc-
tion medium (Cambrex Bio Science, Walkersville, Baltimore,
MD) supplemented with 5% fetal calf serum (FCS). They were
harvested for histological examination, embedded in agarose,
pellets fixed with 10% neutral buffered saline for 20 minutes
and stored in 70% ethanol until processed for paraffin embed-
ding. Proteoglycan production in the ECM was visualised by
toluidine blue staining (Sigma, St. Louis, MO; 0.1% in distilled
water).
Stimulation of AD-MSC to increase proteoglycan and 
collagen type I production
To increase proteoglycan and collagen type I production, 3D
cell culture and exposure to TGFβ were used.
Growth and differentiation of stem cells in 3D scaffold 
culture
Sterile collagen sponge (Gelfoam, Pharmacia & Upjohn Co,
Kalamazoo, MI, USA), an absorbable collagen sponge pre-
pared from purified pig skins previously used in our laboratory
to grow intervertebral disc cells in 3D culture [25], was used
as a 3D scaffold. AD-MSC were suspended in MSCBM at a
concentration of 1 × 107 cells/ml. Droplets of 10 μl (containing
1 × 105 cells) were injected into collagen sponges trimmed
into 0.5 cm3 cubes. An optimum number for maximum prote-
oglycan production in collagen sponge has previously been
found to be 1 × 105 cells/0.5 cm3 of collagen sponge [25].
Replicate collagen sponges were placed on Costar Transwell
Clear Inserts (Corning Incorporated-Life Sciences, Lowell,
MA) in 24-well plates and fed three times per week with 2.0 ml
of MSCBM with 10 ng/ml TGFβ (Cambrex Bio Science, Walk-
ersville, MD) or without TGFβ (control). The typical dose of
TGFβ used in the literature for chondrogenic differentiation is
10 ng/ml [17]. Cells were grown for two to six weeks and
assayed for proteoglycan production in the presence or
absence of TGFβ. Cultures were terminated, fixed in 10% neu-
tral buffered saline for one hour and embedded in paraffin. Col-
lagen sponge was sectioned for immunohistochemical
analysis and stained for ECM proteoglycan production using
toluidine blue (Sigma, St. Louis, MO; 0.1% in distilled water).
Proteoglycan production was also assessed using the 1,9-
dimethylmethylene blue (DMB) assay and by scoring ECM
production after immunohistochemistry.
Cell proliferation was evaluated by seeding AD-MSC in a mon-
olayer in 48-well tissue culture plates at known cell densities
Table 1
Profile of antibodies used in 3D immunohistological and CD marker studies
Antibody Source Dilution
Type I collagen Biodesign International (Kennebunk, ME) 20 μg/ml
Type II collagen Biodesign International (Kennebunk, ME) 20 μg/ml
Decorin R&D Systems, (Minneapolis, MN) 25 μg/ml
Keratin sulphate Seikagaku Corporation, (Tokyo, Japan) 5 μg/ml
Chondroitin sulphate ICN Biomedicals, (Costa Mesa, CA) 20 μg/ml
CD29 Lab Vision Corporation (Fremont, CA) 200 μg/ml
CD34 DakoCytomation (Carpinteria, CA) 50 μg/ml
CD45 DakoCytomation, (Carpinteria, CA) 350 μg/ml
CD105 Lab Vision Corporation (Fremont, CA) 200 μg/ml
3D, three dimensional; CD, cluster of differentiation.Page 3 of 10
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TGFβ. After five days of culture, wells were rinsed and held at
-80°C. A FluoReporter Blue Fluorometric dsDNA Quantitation
kit (Molecular Probes Inc, Eugene, OR) was used to assess
cell proliferation per manufacturer's directions. Tests were run
in duplicate for each culture and results averaged for statistical
analysis.
Assay of total sulphated glycosaminoglycan production
Cells were grown in 3D culture for 14 days in the presence or
absence of TGFβ and assayed for sulphated proteoglycan
production using the DMB assay [26].
Scoring of immunohistochemistry and toluidine blue 
staining
Scoring of slides from immunohistochemical staining of cell-
surface markers, ECM proteins and toluidine blue staining of
total proteoglycans was performed blinded by HG, HT and
MK. The following scoring scale was used: 1 = very slight
localisation; 2 = modest localisation; 3 = abundant localisa-
tion. For accuracy and consistency, previously scored exam-
ples of grades were reviewed before each scoring session; in
addition, random previously scored slides were re-scored to
assure consistency.
Immunohistochemistry
Specimens were fixed in 10% neutral buffered saline for one
hour, transferred to 70% ethyl alcohol and held for paraffin
processing using a Shandon Pathcentre Automated Tissue
Processor (ThermoShandon, Pittsburgh, PA). Collagen
sponges were bisected and the two halves embedded on
edge. Specimens were embedded in Paraplast Plus paraffin
(ThermoShandon, Pittsburgh, PA), and 4 mm serial sections
cut with a Leica RM2025 microtome (Nussloch, Germany)
and mounted on Superfrost-Plus microscope slides (Alle-
giance, McGaw Park, IL).
Immunohistochemical localisation of CD markers, types I and
II collagen, chondroitin sulphate, decorin and keratin sulphate
utilised antibodies used techniques described previously [27]
(Table 1). Negative controls consisted of rabbit IgG (Dako,
Carpinteria, CA; for collagen I and II) or mouse IgG (Dako,
Carpinteria, CA; for all other antibodies) used at the same con-
centration as each tested antibody.
3D co-culture of AD-MSC and human disc cells
Human disc cell studies were performed following approval by
the Carolinas Medical Center's human subjects Institutional
Review Board (IRB Protocol # 08-04-09E). The need for
informed consent was waived because surgical tissue is rou-
tinely discarded at our institution.
To assess the effect of AD-MSC on human annulus disc cells,
a 3D co-culture system was used to measure ECM and prote-
oglycan changes when disc cells were co-cultured in contact
with AD-MSC or grown in CM previously used to feed monol-
ayer AD-MSC cultures. Human annulus cells from surgically
removed lumbar disc tissue (Thompson grades 3 or 4 [28])
were obtained from four surgeries and established in culture
as previously described [29]. Flasks of confluent annulus cells
were rinsed twice with phosphate buffered saline and labeled
in situ with carboxyfluorescein diacetate succinimidyl ester
(CFSE) (10 μM for 10 minutes at 37°C) using established
methods [5,22,30].
Replicate samples of resuspended AD-MSC, labelled annulus
cells, or premixed AD-MSC and annulus cells were injected
into collagen sponges as described above. Cultures and co-
cultures were soaked with 2.0 ml of MSCBM, CM or a 50:50
mixture of the two, and were fed three times per week for two
weeks. Cultures were then assayed for proteoglycan produc-
tion by DMB assay. To calculate proteoglycan production in
co-culture, data was expressed as an increase in sulphated
proteoglycans compared with the predicted value taken as the
sum of the individual control stem and disc cultures [31].
Statistical analysis
Data were analysed using SAS version 8.2 (SAS, USA). A p <
0.05 was considered statistically significant. Standard statisti-
cal methods were used. Data are presented as mean ± SD (n).
Results
Morphology of AD-MSC in monolayer culture
AD-MSC were plated and observed 24 hours a day for three
days and at one week after tissue extraction (data not shown).
After attachment, the cells gradually spread out and assumed
the fibroblastic morphology previously reported for stem cells
[32]. Cells became confluent after approximately one week.
With sequential passaging, the rate of cell proliferation gradu-
ally slowed. The time between passages lengthened from
seven days for P1 and P2, 10 days for P3 to three weeks for
P4 to P6. The total number of passages before cell growth
diminished varied according to the age of the donor sand rat.
In general, AD-MSC from younger sand rats up to age 12
months were passaged six to eight times; AD-MSC from sand
rats older than 12 months were usually only passaged up to
three times.
Characterisation of stem cells
AD-MSC were characterised using the following accepted cri-
teria [23]: adherence to plastic; osteogenic and chondrogenic
differentiation as evidence of multipotent differentiation poten-
tial; and specific surface antigen expression.
Adherence to plastic Cells attached well and displayed a
fibroblastic-like morphology in monolayer culture by three
days.
Osteogenic differentiation of AD-MSC was confirmed by ali-
zarin red staining of mineralised bone matrix deposited in vitroPage 4 of 10
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inducing media (Figures 1a and 1b).
Chondrogenic differentiation of AD-MSC was confirmed by
formation of chondrogenic micromasses in culture and by pos-
itive proteoglycan staining of ECM produced by cells within
the micromasses (Figure 1c). In addition, monolayer AD-MSC
grown in chondrogenic media showing a more rounded phe-
notype typical of chondrocytes (data not shown).
CD marker analysis AD-MSC were also characterised by
localisation of the multipotent mesenchymal stem cell markers
CD105 (approximately 75% of cells were positive) and CD29
(more than 90% of cells were positive) (Figure 2) and negative
localisation of CD 45 and CD34 (data not shown).
Stimulation of AD-MSC by TGFβ
After being established in monolayer, AD-MSC were stimu-
lated to produce a proteoglycan rich ECM by 3D culture in a
collagen sponge and treatment in the presence or absence of
TGFβ.
Cell morphology in monolayer
Within one week of monolayer culture, TGFβ-treated AD-MSC
became rounded and less fibroblast-like in appearance (Fig-
ures 3a and 3b). Compared with control AD-MSC, where con-
fluence was observed in two to three weeks, proliferation of
AD-MSC in the presence of TGFβ slowed gradually, and cells
did not achieve confluency (data not shown).
Cell morphology in 3D culture
When grown in 3D culture, morphological studies of AD-MSC
showed that the AD-MSC grew as rounded cells filling the
cavities in and around the 3D matrix (unlike the typical fibrob-
lastic morphology of monolayer-cultured AD-MSC). Cells cul-
tured within the 3D sponge were rounded, whereas cells
attached to the outer sponge margins were more flattened and
elongated (Figures 3c and 3d).
Figure 1
Osteogenic differentiation of adipose-derived mesenchymal stem cells (AD-MSC)
(AD-MSC). (a) and (b) AD-MSC treated with osteogenic media for 
three weeks stained with Alizarin red. Red staining marks mineralised 
matrix produced by osteoblasts. A at × 4 magnification; (b) at × 105 
magnification. (c) High density cultures showed formation of a chon-
drogenic phenotype when cultured in micromass; pink extracellular 
matrix staining marks proteoglycans stained with toluidine blue × 95.
Figure 2
Immunolocalisation of the mesenchymal stem cell markers from passage one adipose-derived mesenchymal stem cells grown in monolayer. (a) 
CD29 at × 650; (b) CD105 at × 840.Page 5 of 10
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Figure 3
Effect of transforming growth factor beta (TGFβ) in culture. (a) Monol-
ayer culture. Cells show typical fibroblast-like morphology in control 
culture × 180. (b) Monolayer culture. In the presence of TGFβ, mor-
phology changes to a more rounded phenotype × 155. (c) 3D culture. 
In the absence of TGFβ, extracellular matrix contains modest amounts 
of proteoglycans (indicated by pink staining with toluidine blue) × 400. 
(d) 3D culture. Cells produce abundant proteoglycan when cultured 
with TGFβ × 400. (e) Quantitative analysis of proteoglycan shows sig-
nificantly greater formation in the presence of TGFβ. * p < 0.05.
Table 2
Histological grading of proteoglycan extracellular matrix formatio
into 3D matrixa
Age of donor sand rat Number of weeks of cultured
10 weeks 3 to 5
6 months 3 to 6
20 months 3 to 4
aScoring scale: 0 = no localization; 1 = very slight localization; 2 = mode
beta (TGFβ) treated AD-MSC gave a significantly higher score compareBiochemical measurement of proteoglycan production and 
proliferation: effect of 3D growth and TGFβ
Evaluation with the DMB assay showed that TGFβ-treated AD-
MSC in 3D culture had 48% more proteoglycan compared
with AD-MSC in 3D culture alone (p < 0.05; Figure 3e). The
FluoReporter quantitation assay of cell proliferation showed a
four-fold increase in the number of AD-MSC after four days in
monolayer culture (data not shown) for both TGFβ treated and
untreated AD-MSC with no further increase after seven days.
No significant difference in proliferation was seen for TGFβ-
treated AD-MSC compared with untreated AD-MSC.
Morphological studies: effect of TGFβ on AD-MSC 
proteoglycan production
Toluidine blue staining showed the presence of ECM prote-
oglycan between and around the AD-MSC (Figures 3c and
3d). Extensive ECM was present at the edges of the 3D colla-
gen sponge; ECM grading showed that the quantity of ECM
increased between two and four weeks in culture. TGFβ treat-
ment also increased levels of ECM in 3D culture. Semi-quanti-
tative grading of toluidine blue-stained AD-MSC in 3D cultures
showed the TGFβ-treated AD-MSC scored significantly higher
(2.9 +/- 0.15), than the control slides (1.63 +/- 0.20) cultured
without TGFβ (Figures 3c and 3d; Table 2). Paired t-test anal-
ysis showed a significant increase in ECM production for the
TGFβ-treated samples (p < 0.05). Sand rat age did not corre-
late with ECM proteoglycan levels for either TGFβ-treated or
control AD-MSC (Table 2).
Effect of TGFβ on AD-MSC extracellular matrix 
(immunohistochemical analysis)
Immunohistochemical evaluation confirmed the presence of
chondroitin sulphate and keratin sulphate (Figures 4a–d),
types I and II collagen and decorin (data not shown). Localisa-
tion of the ECM proteins was present in cell layers on margins
of the 3D matrix and between cells within the 3D matrix (Figure
4). More intense localisation for all ECM proteins was associ-
ated with TGFβ-treated 3D matrix samples. Slide scoring
showed greater ECM for TGFβ-treated 3D matrix samples
(Table 3). Paired t-test analysis from four experiments showed
TGFβ-treated 3D cultured samples had significantly higher
n by adipose-derived mesenchymal stem cells (AD-MSC) seeded 
Mean histological grading score (mean +/- standard deviation)
- TGFβ + TGFβb
2.0 ± 0.0 (3) 3.0 ± 0.0 (3)
1.0 ± 0.0 (3) 2.7 ± 0.47 (3)
1.3 (2) 3.3 (2)
st localization; 3 = abundant localisation. bTransforming growth factor 
d with untreated cells (p < 0.05).
Available online http://arthritis-research.com/content/10/4/R89scores for collagen I, keratin sulphate and decorin (but not for
chondroitin sulphate and collagen II) (Table 3; p < 0.05).
Effect of co-culture of AD-MSC with annulus cells on 
proteoglycan production
Evaluation with the DMB assay showed that proteoglycan pro-
duction increased by approximately 20% (Figure 5). This was
assuming a 50:50 ratio of AD-MSC and annulus cells in co-
culture compared with the predicted value calculated from the
sum of the proteoglycan contents of individual cultures of AD-
MSC and annulus cells. Data from eight DMB analyses of 3D
cultured AD-MSC alone, annulus cells alone, and AD-MSC
and annulus co-cultures were analysed using a repeated
measure analysis of variance followed by paired t-test analysis.
Results were highly significant for AD-MSC compared with
co-culture and annulus cells compared with co-culture (Figure
5; p < 0.05). No significant increase in proteoglycan produc-
tion was seen for disc cells alone treated with CM from AD-
MSC. When the ratio of stem cells to disc cells was increased
from 1:1, 2:1 or 3:1, proteoglycan production did not change
significantly (data not shown). Anti-CFSE antibody labelling
clearly showed the presence of labelled disc cells in the 3D
culture after two weeks. When disc cells were cultured alone,
the CFSE label was clearly visible in almost all cells. Both
labelled and unlabelled cells were visible in co-cultures at
about a 1:1 ratio, thus verifying that the annulus cells were still
present and were not depleted during co-culture.
Discussion
This study had two main goals: to test whether the stimulation
of AD-MSC increased extracellular proteoglycan production
and collagen type I using 3D culture in the presence or
absence of TGFβ; and to examine the influence of AD-MSC on
annulus cells by testing for a synergistic effect on proteogly-
can production by 3D co-culture.
AD-MSC were stimulated to produce several known compo-
nents of the annulus ECM after treatment with TGFβ in 3D cul-
ture, confirmed by a 48% increase in proteoglycan content as
assayed by DMB analysis and immunohistochemical identifi-
cation of ECM components. Immunohistochemistry showed
that expression of collagen type I, keratin sulphate and decorin
was significantly increased in the presence of TGFβ. Chon-
droitin sulphate and collagen type II showed similar high
expression levels in the presence or absence of TGFβ. TGFβ
stimulated ECM production is known to occur through SMAD
signalling transcription factors and through mitogen activated
protein kinase. Chondrogenic gene expression and protein
synthesis have been directly correlated with concentration and
length of exposure to TGFβ [33]. We speculated that TGFβ
stimulation of ECM production by AD-MSC occurred through
these pathways. Previously, comparisons of disc and cartilage
tissue have identified some ECM similarities. However,
intervertebrate disc tissue, in contrast to the articular cartilage
phenotype, expresses collagen type I [32]. We show the 3D
matrix synthesised by AD-MSC was strongly positive for colla-
gen type I.
TGFβ stimulation of BM-MSC has been previously studied
using a micromass pellet culture system. Microarray showed
gene expression was found to be closer to annulus fibrosus
cells than chondrocytes [32]. Our present work used a 3D col-
lagen sponge for cell growth which, as well as allowing 3D
growth and differentiation, also offered a scaffold system to
facilitate cell attachment, growth and differentiation. Collagen
sponge is flexible with an open porous matrix allowing space
for cells to attach and ECM to form. In a surgical situation, it
could be sized to fit required dimensions. The matrix will slowly
dissolve allowing integration of cells and ECM into the sur-
rounding tissue. Hypoxia and TGFβ have also been used to
drive BM-MSC differentiation towards a nucleus pulposus
phenotype [34].
Table 3
Immunohistochemical characterisation of extracellular matrix (ECM) formed by adipose-derived mesenchymal stem cells (AD-MSC) 
in 3D culture for two to five weeksa
ECM protein Mean histological grading score 
Mean of four experiments +/- standard deviation
- TGFβ + TGFβ
Keratin sulphateb 1.5 ± 0.58 2.5 ± 0.58
Chondroitin sulphate 2.5 ± 0.58 3.0 ± 0.00
Collagenb type I 2.4 ± 0.42 3.0 ± 0.00
Collagen type II 2.4 ± 0.42 2.6 ± 0.42
Decorinb 1.5 ± 0.58 2.3 ± 0.50
aScoring scale: 1 = very slight localization; 2 = modest localisation; 3 = abundant localisation. bTranforming growth factor beta (TGFβ) treated 
cells gave a significantly higher score compared with untreated cells (p < 0.05).Page 7 of 10
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sus and nucleus pulposus. AD-MSC have feasibility in the
repair of both the nucleus pulposus and annulus fibrosus
region of the disc. AD-MSC, either in suspension or on an
injectable matrix, could be injected directly into the nucleus
pulposus where production of proteoglycan and collagen
could potentially be stimulated. Before implantation, in vitro
stimulation with chondrogenic media would be expected to
produce ECM richer in collagen type II, the major collagen of
the nucleus pulposus. It should be noted that the ECM com-
ponents identified here are not exclusive to the annulus fibro-
sis, and are also present in the ECM of the nucleus pulposus
and cartilage. There is currently no standard set of genes that
'define' disc cells.
Although disc cells have some chondrocyte-like features, it is
important to note that chondrocytes and annulus cells are two
completely different mature cell types as illustrated by the
matrix they produce and by their biochemistry [12]. Previous
work [35] on type II A pro-collagen in the developing human
disc found that disc cells show different processing of this
pro-collagen than is seen in chondrocytes. Studies by Razaq
et al. [36] on the regulation of intracellular pH by bovine disc
cells also revealed that the disc cells differ from chondrocytes
in that they use a HCO3-dependent system to regulate intrac-
ellular pH. Furthermore, new evidence from our laboratory
shows that annulus cells are highly specialised, polarised cells
[37].
In the present study we show that co-culture of human annulus
and sand rat AD-MSC in 3D culture resulted in a 20%
increase in proteoglycan production. Similar to pellet co-cul-
ture, AD-MSC and annulus cells were able to coexist and pro-
duce a proteoglycan-rich ECM. At present we do not know
whether one or both cell types were responsible for the total
amount of enhanced synthesis seen. The collagen 3D sponge
used here allowed 3D interactions between neighbouring
cells, perhaps through contact or growth factor upregulation
leading to increased matrix production. TGFβ, IGF-1, epider-
mal growth factor and platelet-derived growth factor were sig-
nificantly upregulated in direct cell-to-cell contact co-culture
between nucleus pulposus cells and BM-MSC [38]. The syn-
ergistic increase in proteoglycan production may be caused
by effects such as secreted growth factors released by either
cell type enhancing the overall ECM production, or by modifi-
cation of the microenvironment of the 3D matrix through dep-
osition of ECM components by either the AD-MSC or the
annulus cells. Growth factor release in situ has been shown to
have an effect on mesenchymal stem cells. When the ratio of
AD-MSC to annulus cells was increased from 1:1 to 2:1 or
3:1, no further increase or decrease in proteoglycan content
was present. A higher ratio of cells may therefore not be
required to further stimulate annulus cells.
Figure 5
Increase in proteoglycan concentration for 3D co cultured adipose-derived mesenchymal stem cells (AD-MSC) and annulus cells compa ed with parate ul ure of AD-MSC and annulus cells one
derived mesenchymal stem cells (AD-MSC) and annulus cells com-
pared with separate culture of AD-MSC and annulus cells alone. Data 
from eight 1,9-dimethylmethylene blue analyses were examined using 
repeated measure analysis of variance. p < 0.05.
Figure 4
Immunohistochemical documentation of extracellular matrix formed by sand rat adipos -derived mesenchymal stem s in 3D cultu e in theprese ce (b, d) or abs n e (a, c) of transfo ming growth factor be a (TGFβ)
sand rat adipose-derived mesenchymal stem cells in 3D culture in the 
presence (b, d) or absence (a, c) of transforming growth factor beta 
(TGFβ). Note the enhanced keratin sulphate (KS) formed when TGFβ is 
present (b). Chondroitin sulphate (CS) also was enhanced with TGFβ 
(d) compared with control (c) × 360. Immunolocalization product is 
brown.Page 8 of 10
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Available online http://arthritis-research.com/content/10/4/R89Previous work from our laboratory has shown the presence of
a significant population of senescent cells in the disc, with a
greater proportion of senescent cells present in more degen-
erated discs [3]. Other studies [39,40] also independently ver-
ified a high proportion of senescent disc cells. It is possible
that senescent disc cells may respond favourably to direct
contact with mesenchymal stem cells, potentially allowing
resumption of matrix production.
Stimulation of annulus cells by AD-MSC potentially offers a
practical approach to autologous disc regeneration and repair.
Lu et al. used micromass co-culture to show nucleus pulposus
cells could secret soluble factors to direct stem cells towards
the nucleus pulposus phenotype [41]. Previous work on inter-
actions of adult mesenchymal stem cells and disc cells by Le
Visage et al. [20] showed that annulus, but not nucleus, cells
co-cultured in chondrogenic pellets with mesenchymal stem
cells had approximately 50% higher proteoglycan content
than would be predicted from separate culture alone. In order
to test the effect of secreted growth factors, we added CM
from AD-MSC cultures to annulus cells in 3D matrix culture. In
agreement with a previous study [20] where secreted factors
from one cell type were cultured with mesenchymal stem cells,
no increase in proteoglycan production was seen.
Conclusion
Here we investigated growth of AD-MSC and annulus cells in
a 3D environment. Adult AD-MSC derived from the sand rat
could be stimulated to produce matrix components found in
the annulus by exposure to TGFβ in 3D culture. Co-culture of
human annulus cells and sand rat AD-MSC in 3D culture
resulted in significantly increased proteoglycan production.
Results support the hypothesis that AD-MSC may potentially
be useful in cell-based therapy for disc degeneration.
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